- Home
- NCA vs SGHT Comparison
NCA vs SGHT Comparison
Compare NCA & SGHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCA
- SGHT
- Stock Information
- Founded
- NCA 1987
- SGHT 2011
- Country
- NCA United States
- SGHT United States
- Employees
- NCA N/A
- SGHT N/A
- Industry
- NCA Investment Managers
- SGHT Medical Specialities
- Sector
- NCA Finance
- SGHT Health Care
- Exchange
- NCA Nasdaq
- SGHT Nasdaq
- Market Cap
- NCA 288.4M
- SGHT 304.4M
- IPO Year
- NCA N/A
- SGHT 2021
- Fundamental
- Price
- NCA $8.75
- SGHT $4.02
- Analyst Decision
- NCA
- SGHT Buy
- Analyst Count
- NCA 0
- SGHT 6
- Target Price
- NCA N/A
- SGHT $6.80
- AVG Volume (30 Days)
- NCA 59.6K
- SGHT 281.6K
- Earning Date
- NCA 01-01-0001
- SGHT 11-07-2024
- Dividend Yield
- NCA 3.92%
- SGHT N/A
- EPS Growth
- NCA N/A
- SGHT N/A
- EPS
- NCA N/A
- SGHT N/A
- Revenue
- NCA N/A
- SGHT $79,543,000.00
- Revenue This Year
- NCA N/A
- SGHT $2.18
- Revenue Next Year
- NCA N/A
- SGHT $8.14
- P/E Ratio
- NCA N/A
- SGHT N/A
- Revenue Growth
- NCA N/A
- SGHT N/A
- 52 Week Low
- NCA $7.77
- SGHT $2.58
- 52 Week High
- NCA $9.12
- SGHT $8.45
- Technical
- Relative Strength Index (RSI)
- NCA 44.13
- SGHT 38.25
- Support Level
- NCA $8.64
- SGHT $3.86
- Resistance Level
- NCA $8.85
- SGHT $4.11
- Average True Range (ATR)
- NCA 0.11
- SGHT 0.21
- MACD
- NCA 0.01
- SGHT 0.06
- Stochastic Oscillator
- NCA 66.67
- SGHT 36.26
About NCA Nuveen California Municipal Value Fund
Nuveen California Municipal Value Fund Inc is a diversified closed-end management investment company. Its primary objective is to provide current income exempt from regular federal and California income taxes. The fund's secondary objective is to enhance portfolio value relative to the California municipal bond market by investing in tax-exempt California municipal securities that the Fund's investment adviser and/or the Fund's sub-adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.
About SGHT Sight Sciences Inc.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.